| 摘要 |
The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample. |
| 申请人 |
OREGON HEALTH & SCIENCE UNIVERSITY;OSLO UNIVERSITY HOSPITAL HF;CLEVELAND CLINIC;BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA;BRITISH COLUMBIA CANCER AGENCY BRANCH;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY;UNIVERSITAT DE BARCELONA;HOSPITAL CLINIC DE BARCELONA;ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVIERSITY OF ARIZONA;JULIUS-MAXIMILIANS-UNIVERSITY OF WUERZBURG |
发明人 |
STAUDT, LOUIS M.;WRIGHT, GEORGE W.;SCOTT, DAVID WILLIAM;CONNORS, JOSEPH M.;GASCOYNE, RANDY D.;RIMSZA, LISA;CAMPO GUERRI, ELIAS;GREINER, TIMOTHY C.;COOK, JAMES ROBERT;FU, KAI;WILLIAMS, PAUL MICHAEL;LIH, CHIH-JIAN;JAFFE, ELAINE S.;BRAZIEL, RITA M.;ROSENWALD, ANDREAS;SMELAND, ERLEND B.;CHAN, WING C.;OTT, GERMAN;DELABIE, JAN;WEISENBURGER, DENNIS |
